Market News

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries, today announced the second group of nonprofit organizations to receive funding as part of its Good Green Grant Program.

"We are proud to partner with five more nonprofit organizations on their mission to create meaningful change in local communities and correct the social and economic injustices created by cannabis prohibition," said Green Thumb Founder and Chief Executive Officer Ben Kovler. "The Good Green movement is committed to re-directing resources to organizations expanding access and opportunities for communities and individuals impacted by the failed War on Drugs. Bit by bit, we can deliver lasting, positive change in the communities that we serve."

First launched in the fall of 2021, Good Green offers high-quality and affordable popcorn flower products. Sales from Good Green products fund grants awarded to nonprofit organizations that give back to communities disproportionately affected by the War on Drugs. Each organization selected encompasses one or more of Good Green's three core pillars: education, employment and expungement. The five organizations will receive unrestricted grants of $60,000 that will advance each organization's mission and objectives. Good Green's second round of beneficiaries include:

  • Ex-Cons for Community and Social Change : Ex-Cons for Community and Social Change is a Chicago-based organization linking communities to programs and resources to change the dynamic of trauma within communities by reducing recidivism.

"It's amazing to receive this generous grant from the team at Good Green which will aid our efforts in continuing to engage with communities in Chicago through re-entry programs and critical resources often underfunded by the state." – Tyrone F. Muhammad, Executive Director

  • Growing Home : Growing Home uses their organic urban farm in Englewood to provide paid workforce development and agricultural training for formerly incarcerated individuals and other community members in Chicago facing barriers to employment. The organization also helps trainees access legal, medical, childcare and housing services to facilitate the re-entry process, alongside providing organic healthy food at affordable prices in their community.

"Growing Home is extremely grateful to partner with Good Green to create an even greater impact in Chicago. This grant will allow us to serve over 80 participants in our workforce development programs this year, many of whom have been impacted by the War on Drugs." – Janelle St. John, Executive Director

  • Greyston Foundation : Based in Yonkers, New York, The Greyston Foundation aims to unlock the power of human potential through inclusive employment opportunities. In the past three years, The Greyston Employment Opportunity Center (GEOC) has provided training and education programs, youth services, and transitional employment services to over 5,000 individuals who have faced barriers to meaningful employment.

"Good Green's grant allows our organization to advocate for Open Hiring ® and more inclusive employment practices on a national scale to create more job opportunities for those with employment barriers. Greyston Bakery has a 40-year track record of unlocking human potential through Open Hiring ® . We want other businesses to replicate this innovative approach to finding great employees." – Joseph D. Kenner, President and CEO

  • i.c.stars : Over the past 23 years, i.c.stars has provided coding, business and leadership training to help promising adults in Chicago and Milwaukee secure high-growth jobs in the technology industry. The four-month program trains talented, under-resourced young adults including those who are formerly incarcerated or who have been affected by the War on Drugs, and has a 90 percent job placement rate.

"We are honored to work with Good Green to help create opportunities in the tech sector for individuals facing barriers. Thank you for being a partner in our work."
– Sandee Kastrul, President and CEO

  • TakeRoot Justice : TakeRoot Justice provides legal research and policy support to grassroots and community-based groups in New York City working to dismantle racial, economic and social oppression. The organization formed HAPPEN, a dedicated social justice program in 2016, to increase police accountability, combat discriminatory policing and support community-led campaigns for safety.

"Thank you to Good Green for selecting TakeRoot Justice as a grant recipient. This grant will enable us to grow our work with marginalized New Yorkers organizing to stabilize their communities and vision their own futures." – Sadia Rahman, Interim Co-Director

Good Green is committed to bringing responsible consumers and change-making organizations together to create real, lasting progress against the War on Drugs. The brand's current product offerings, including indica, sativa and hybrid popcorn flower, are available in Illinois, Maryland, Massachusetts, New Jersey, Pennsylvania and Virginia.

The Good Green Grant Program's third round of applications will open to local 501(c)3 organizations on June 1, 2022 through August 19. For more information on Good Green's nonprofit application process, winners and product, please visit www.good.green .

About Green Thumb Industries :
Green Thumb Industries Inc. ("Green Thumb"), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities, 77 open retail locations and operations across 15 U.S. markets. Established in 2014, Green Thumb employs approximately 3,800 people and serves millions of patients and customers each year. The company was named to Crain's Fast 50 list in 2021 and a Best Workplace by MG Retailer magazine in 2018, 2019 and 2021. More information is available at www.GTIgrows.com .

Investor Contact: Media Contact:
Andy Grossman Leah Rosenfeld
EVP, Capital Markets & Investor Relations Senior Director, External Communications
InvestorRelations@gtigrows.com Leah.Rosenfeld@gtigrows.com
310-622-8257 847-951-5324


Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/514f678b-5c19-4eb7-affa-e8fe81f53d36

https://www.globenewswire.com/NewsRoom/AttachmentNg/30a1c444-5f53-4033-b217-1734b7cd4406

https://www.globenewswire.com/NewsRoom/AttachmentNg/742ff57e-5dbd-467b-9899-e8b19e7daa17

https://www.globenewswire.com/NewsRoom/AttachmentNg/9196ad24-8f22-4450-91ea-3b3c8460ef25


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GTII:CNX,GTBIF

Centurion Announces Update on Cannabis Spinout Transaction, Share Consolidation, and Change of Transfer Agent

Centurion Minerals Ltd. (TSXV: CTN) (the "Company") is pleased to update shareholders on progress regarding previously announced plans that include:

  • distributing shares to its shareholders in a wholly owned subsidiary ("SpinCo") created to complete the previously announced, "HAI Beverage/CannaEden Group" cannabis transaction; and,

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the "Meeting") shareholders voting in person or by proxy held in total 265,763,587 common shares of the Company, representing 70.76% of the total number of common shares of the Company outstanding.

Each of the directors listed as a nominee in the Company's proxy statement dated April 29, 2022 (the "Proxy Statement") was elected as a director of the Company, with each director receiving in excess of 91.6% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Khalifa Kush Takes Michigan Higher

TerrAscend introduces Wiz Khalifa's flower in Gage dispensaries starting June 25 th

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the launch of Khalifa Kush ("KK"), a premium cannabis brand founded by Grammy ® Award-nominated recording artist Wiz Khalifa at Gage Cannabis dispensaries in Michigan starting Saturday, June 25th .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

Avicanna Inc. (" Avicanna " or the " Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the sale of its stake in Sativa Nativa S.A.S. ( "Sativa Nativa" ), which was the Company's secondary majority owned Colombian subsidiary.

The aggregate price paid by the purchaser for the Company´s shares in Sativa Nativa was approximately CAD $675,000 in addition to a potential premium of CAD $130,000 subject to the accomplishment of specific short-term milestones. The transaction allows the Company to eliminate redundancies, reduce its operational costs and generate efficiencies across its South American operations by focusing its supply chain efforts at its much larger and more operationally advanced majority owned subsidiary Santa Marta Golden Hemp ("SMGH"). The operations at SMGH have been the source of the company's Aureus-branded commercial exports to 16 countries and include the cultivation, extraction and production of cannabinoid raw materials including active pharmaceutical ingredients and seeds. SMGH is also the source of the Company's cannabinoids for most of its cosmetic and pharmaceutical preparations.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Goodness Growth Holdings Launches HiColor Cannabis Chews in New York

HiColor™ Cannabis-infused chews are now available in five flavors

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the launch of HiColor™ cannabis-infused chews in New York which are now available through the Company's retail and wholesale channels in the New York market. The new line of cannabis-infused edibles is now available in five gourmet flavors and two formulations.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) ("Ginkgo"), the leading horizontal platform for cell programming, today announced the achievement of the third target productivity milestone in their partnership to produce eight cultured cannabinoids. Using Ginkgo's platform for organism design and development, Cronos has successfully achieved the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid hypothesized to reduce the appetite-enhancing property of THC. Access to additional rare cannabinoids will support Cronos' innovation pipeline and commercialization strategy.

(PRNewsfoto/Ginkgo Bioworks)

Launched in 2018 with the goal of accessing rare molecules in the cannabis plant to create innovative and differentiated products that would otherwise be cost-prohibitive, the partnership between Cronos and Ginkgo aims to produce cultured cannabinoids at industrial scale. The program combines Cronos' deep understanding of the biological structure and function of cannabinoids with Ginkgo's vast experience designing microorganisms for the production of cultured products across pharmaceuticals, agriculture and more.

In August 2021 , Ginkgo and Cronos announced the achievement of its first equity milestone for cannabigerolic acid (CBGA). In October 2021 , Cronos launched its first cultured CBG product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy , which quickly gained consumer awareness, and according to Hifyre data has achieved 2.4% market share in the gummies category in Canada as of the week-ended June 11, 2022 . Cronos went on to launch its SPINACH FEELZ™ Chill Bliss 7:1 THC|CBG vape in January 2022 .

"Continuing to hit these productivity milestones in partnership with Ginkgo fuels our innovation pipeline focused on creating borderless products utilizing rare cannabinoids that amplify and differentiate the consumer experience," said Mike Gorenstein , Chairman, President and CEO of Cronos. "We are excited about the possibilities that THCV is expected to give us and look forward to getting more products with rare cannabinoids into market."

"Working with Cronos to develop innovations in cannabis is an opportunity for us to apply synthetic biology in a way that is helping bring the cannabis industry forward and make a real impact on its market and the customers it serves," said Jason Kelly, CEO and cofounder of Ginkgo Bioworks. "The progress we've made thus far in our collaboration is a true testament to both the potential of synthetic biology and the world-class teams at Cronos and Ginkgo."

As a result of the achievement of the final productivity target for THCV, Cronos has issued to Ginkgo approximately 2.2 million common shares.

About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos  is building an iconic brand portfolio. Cronos diverse international brand portfolio includes Spinach ® , PEACE NATURALS ® , Lord Jones ® , Happy Dance ® and PEACE+™. For more information about Cronos and its brands, please visit: thecronosgroup.com .

CRONOS MEDIA CONTACT:
media.relations@thecronosgroup.com

CRONOS INVESTOR CONTACT:
investor.relations@thecronosgroup.com

About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com .

GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com

GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com

Forward-looking Statements of Cronos Group Inc.
This press release may contain information that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws (collectively, "Forward-looking Statements"). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Forward-Looking Statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact. Forward-Looking Statements include, but are not limited to, statements with respect to: Cronos' expectations regarding the potential success of, and the costs and benefits associated with, its partnership with Ginkgo; expectations about the development of the cannabis industry and potential demand for cultured cannabinoids; Cronos' commercialization and planned THCV product launch; the partnership's aim to develop eight cultured cannabinoids; Cronos' and Ginkgo's positioning to elevate the cannabis industry through cannabinoid and product innovation to unlock the next generation of its potential; the use of Cronos' and Ginkgo's combined capabilities to make the benefits of cannabinoids more accessible to consumers; and Cronos' intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Cronos' Annual Report on Form 10-K for the year ended December 31, 2021 and Quarterly Report on Form 10-Q for the period ended March 31, 2022 , both have which been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar , respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the potential success of the partnership and Ginkgo's cell programming platform. These forward-looking statements generally are identified by the words "believe," "can," "project," "potential," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the effect of Ginkgo's business combination with Soaring Eagle Acquisition Corp. ("Soaring Eagle") on Ginkgo's business relationships, performance, and business generally, (ii) risks that the business combination disrupts current plans of Ginkgo and potential difficulties in Ginkgo's employee retention, (iii) the outcome of any legal proceedings that may be instituted against Ginkgo related to its business combination with Soaring Eagle, (iv) volatility in the price of Ginkgo's securities now that it is a public company due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, changes in laws and regulations affecting Ginkgo's business and changes in the combined capital structure, (v) the ability to implement business plans, forecasts, and other expectations after the completion of the business combination, and identify and realize additional opportunities, (vi) the risk of downturns in demand for products using synthetic biology, (vii) the unpredictability of the duration of the COVID-19 pandemic and the demand for COVID-19 testing and the commercial viability of our COVID-19 testing business, and (viii) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of Ginkgo's quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission (the "SEC") on May 16, 2022 and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Ginkgo does not give any assurance that it will achieve its expectations.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/cronos-group-and-ginkgo-bioworks-announce-achievement-of-thcv-equity-milestone-301571428.html

SOURCE Ginkgo Bioworks

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×